Global Statin Market Growth 2023-2029

Global Statin Market Growth 2023-2029

Statins are special class of drugs that helps in lowering of blood cholesterol level in the body. This is prescribed to lower down the low density lipoprotein (LDL) cholesterol in the body and thus reduce mortality in high risk patients.

LPI (LP Information)' newest research report, the “Statin Industry Forecast” looks at past sales and reviews total world Statin sales in 2022, providing a comprehensive analysis by region and market sector of projected Statin sales for 2023 through 2029. With Statin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Statin industry.

This Insight Report provides a comprehensive analysis of the global Statin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Statin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Statin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Statin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Statin.

The global Statin market size is projected to grow from US$ 14120 million in 2022 to US$ 16110 million in 2029; it is expected to grow at a CAGR of 16110 from 2023 to 2029.

Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide. As per the WHO, Europe followed by North America has witnessed highest elevated total cholesterol level worldwide. There has been a significant rise in patients with obesity, cardiovascular diseases and diabetes which in turn is expected to drive the demand for statins worldwide. In North America, over 70% American adults are suffering from LDL cholesterol. As such, demand for effective treatment of LDL cholesterol has led to increased demand of statins globally. Furthermore, increase in healthcare expenditure in emerging regions along with technological advancement, modern healthcare amenities, and various cholesterol related healthcare campaign is expected to boost overall demand for stains worldwide.

This report presents a comprehensive overview, market shares, and growth opportunities of Statin market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others

Segmentation by application
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma

Key Questions Addressed in this Report

What is the 10-year outlook for the global Statin market?

What factors are driving Statin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Statin market opportunities vary by end market size?

How does Statin break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.